Effects of Beta Blockers on Symptoms and Functional Capacity in Heart Failure

This publication has 16 references indexed in Scilit:

• The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
  Published by Elsevier ,2010
• Safety and efficacy of carvedilol in severe heart failure
  Journal of Cardiac Failure, 1997
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure
  Circulation, 1995
• Effects of Carvedilol, a Vasodilator–β-Blocker, in Patients With Congestive Heart Failure Due to Ischemic Heart Disease
  Circulation, 1995
• Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study
  Journal of the American College of Cardiology, 1995
• Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
  Journal of the American College of Cardiology, 1994
• Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
  The Lancet, 1993
• Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents
  The American Journal of Cardiology, 1993
• Rationale for beta-adrenergic blocking drugs in cardiomyopathy
  The American Journal of Cardiology, 1985